You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 2801 to 2825 of about 5988
Next 25
07/05/2011
IBTA E NEWS JUNE 2011
07/01/2011
Variation in Make-Up of Generic Epilepsy Drugs Can Lead to Dosing Problems, Study Suggests
FDA Warns of Cognitive Delay in Offspring With Valproate
06/29/2011
Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients.
Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial.
Potential Role for Valproate in the Treatment of High-Risk Brain Tumors of Childhood-Results from a Retrospective Observational Cohort Study. *****Editor`s note: everyone should read this.*****
Brain tumor Symposium for Patients and families in Los Angeles, Sept 24!
Gamma Knife offers new treatment possibilities for brain surgeries
06/28/2011
New Fundraiser for Brain Tumor Research: TRAVEL FOR THE CAUSE
06/22/2011
Slow Growth of Childhood Brain Tumors Explained
06/18/2011
3rd Annual Brain Cancer Symposium Saturday, June 25, 2011 9:00-3:30 pm
06/16/2011
Concomitant temozolomide and radiotherapy versus radiotherapy alone for treatment of newly diagnosed glioblastoma multiforme.
Specialised Therapeutics to License Brain Tumour Visualisation Drug Gliolan in Australia & NZ
Engineering the brain tumor microenvironment enhances the efficacy of dendritic cells` vaccination: implications for clinical trials design.
Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study .
Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.
Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience.
Tumor treating fields: concept, evidence and future.
Voices Against Brain Cancer`s Annual Gala in NY is tonight!
06/14/2011
"Navigating the Insurance Maze " - a free seminar for individuals and families coping with all types of brain tumors
06/13/2011
Stemline Therapeutics Announces Oral Presentation of Positive Phase I/II Trial Results with Novel Brain Cancer Vaccine at ASCO
06/10/2011
FDA Gives Green Light to Simultaneous PET/MRI System
06/07/2011
Tocagen`s First-in-Human Clinical Trial of Toca 511 Enrolling Patients with High Grade Glioma
Treatment with OPAXIO® (Paclitaxel Poliglumex),Temozolomide and Radiotherapy Results in Encouraging Progression Free Survival in Patients With High Grade Malignant Brain Tumor